Cargando…
Loading, please waitMesenchymal stem cell (MSC) protocols at a COFEPRIS-regulated clinic. More than 3,360 patients evaluated, physician-led, bilingual care for international and Mexican patients.
Stem cell therapy is a branch of regenerative medicine that uses mesenchymal stem cells (MSCs) to support the body's own repair mechanisms. MSCs are multipotent cells with a well-documented ability to modulate inflammation, secrete growth factors, and orchestrate tissue regeneration through paracrine signaling. They are typically sourced from umbilical cord tissue (Wharton's jelly), bone marrow, or adipose tissue, expanded under sterile laboratory conditions, and administered by a licensed physician.
The mechanism of action is largely paracrine: MSCs release exosomes, cytokines, and growth factors that recruit local progenitor cells, dampen chronic inflammation, and create an environment in which damaged tissue can repair itself. They do not simply replace lost cells — they signal. This is why a single application can produce systemic effects when administered intravenously, or highly localized effects when injected directly into a joint or target tissue.
MSCs are also immunoprivileged, which is why allogeneic (donor-derived) cells can be administered without HLA matching in carefully screened protocols. Decades of preclinical research and a growing body of clinical evidence support their safety profile and their utility as an adjunct to standard care in osteoarthritis, autoimmune conditions, sports injuries, and selected anti-aging applications.
Every patient is evaluated case by case. Stem cell therapy is investigational for many indications — we determine candidacy based on diagnosis, imaging, labs, and treatment history. The conditions below are the ones we see most frequently across orthopedic, autoimmune, aesthetic, and metabolic referrals.
Stem cell therapy is a medical decision, not a transaction. Every patient moves through the same five-stage path so we never apply a protocol without a clear indication.
A licensed physician reviews your reason for seeking care, current diagnosis, prior treatments, and goals. We tell you honestly whether a regenerative protocol is plausible for your case.
Schedule a free consultationComprehensive review of your medical history, recent labs, and imaging studies (MRI, X-ray, ultrasound). We may request additional workup before confirming candidacy.
Your physician designs an individualized protocol — cell type (autologous vs. allogeneic Wharton's-jelly MSCs), dosing, route of administration (IV vs. local), and any combination with PRP, exosomes, or peptides.
Sessions are performed at the Regeneris Therapy clinic in Cancún under sterile, COFEPRIS-regulated conditions, supervised throughout by a physician. International patients are coordinated end-to-end.
Scheduled check-ins at 2, 4, 8, and 12 weeks, with biomarker re-testing when indicated. The medical team remains reachable by WhatsApp throughout.
Regenerative medicine in Latin America has a wide spectrum of providers, from rigorous physician-led clinics to questionable cash-only operations. We hold ourselves to the higher end of that spectrum deliberately.
Our clinic holds an active Aviso Sanitario (Health Notice) and Aviso de Publicidad (Advertising Notice) with COFEPRIS, Mexico's federal health regulator equivalent to the U.S. FDA. License numbers are listed in our footer for verification.
Every patient is evaluated and treated by a licensed Mexican physician with a published cédula profesional issued by SEP. Meet our medical team directly — none of our credentials are anonymous.
Our cellular sourcing chain follows International Society for Cell & Gene Therapy (ISCT) and International Society of Blood Transfusion (ISBT) consensus guidance for MSC characterization, donor screening, and release criteria.
Our medical team has evaluated more than 3,360 patients across orthopedic, autoimmune, aesthetic, and metabolic referrals — depth that allows us to set realistic expectations from the first consultation.
Consultations, treatment, and follow-up are delivered fluently in English and Spanish. International patients receive pre-travel coordination, transfers, and a single point of contact throughout their stay in Cancún.
Cellular products are processed in COFEPRIS-certified laboratories under controlled sterile conditions, with documented donor screening, viability assays, and release criteria for every batch.
Dr. Claudia Labastida
Head Physician · Cédula 12128801 · Universidad Anáhuac
Not all stem cells are interchangeable. The choice between autologous and allogeneic, and between cellular sources, is a medical decision driven by your diagnosis, age, and the goals of your protocol.
MSCs are the workhorse of regenerative medicine. They modulate inflammation, secrete growth factors, and create a healing environment through paracrine signaling. They can be administered systemically (intravenously) or locally (intra-articular, intradiscal, intradermal) depending on the protocol.
Sourced from screened, ethically donated post-birth umbilical cord tissue (the parents and newborn are not affected). Wharton's-jelly MSCs are young, immunoprivileged, and consistent batch-to-batch — making them ideal for allogeneic protocols in patients whose own cell reserves may be depleted.
Autologous cells come from the patient (bone marrow or adipose tissue). Allogeneic cells come from a screened donor (most commonly umbilical cord). Each has trade-offs in age-related cell quality, processing time, and clinical indication. Your physician explains both options during evaluation.
Read the autologous vs. allogeneic deep diveLooking for a combined protocol? Review the full stem cell therapy service detail or the guide on considering stem cell therapy.
Stem cell therapy uses mesenchymal stem cells (MSCs) — multipotent cells that modulate inflammation and signal tissue repair — to support the body's own regenerative capacity. MSCs do most of their work by paracrine signaling: they release exosomes, growth factors, and cytokines that recruit local progenitor cells and create an environment in which damaged tissue can repair itself. They are administered either intravenously for systemic effect or locally for targeted joint, spine, scalp, or skin applications.
Revisado por Dr. Claudia Labastida · 2026-05-27
Yes. Mexico's federal health authority, COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios), regulates the use of cellular therapies. Authorized clinics must hold an active Aviso Sanitario (Health Notice) and follow regulated sourcing, processing, and clinical-practice protocols. Regeneris Therapy holds Aviso Sanitario 2323025036X00098 and Aviso de Publicidad 2323022002A00053 — both verifiable through COFEPRIS. Be cautious of any provider in Mexico that does not display its license numbers.
Revisado por Dr. Claudia Labastida · 2026-05-27
Duration varies by indication, dose, and the patient's baseline condition. In knee osteoarthritis, peer-reviewed studies report symptomatic improvement lasting 12 to 24 months in many patients. In autoimmune indications, the goal is often to reduce flare frequency rather than a permanent cure. Anti-aging and longevity protocols are designed as ongoing programs with periodic boosters. Your physician sets realistic expectations during the eligibility evaluation.
Revisado por Dr. Claudia Labastida · 2026-05-27
Mesenchymal stem cells have a well-documented safety profile in published clinical research. The most common short-term effects are mild — transient fatigue, low-grade fever, or soreness at the injection site for local applications, usually resolving within 24 to 72 hours. Allergic reactions and infection are rare when the cellular product comes from a certified laboratory chain and the procedure is performed under sterile conditions. All risks are discussed individually as part of informed consent.
Revisado por Dr. Claudia Labastida · 2026-05-27
Cost depends on the protocol — cell type and source, dose, route of administration, and any combination therapies (PRP, exosomes, peptides). For international patients, treatment in Cancún is typically a fraction of comparable cellular protocols quoted in the U.S., while delivered under COFEPRIS regulation. We provide a transparent quote in USD and MXN after the eligibility evaluation. We do not quote prices before a medical evaluation because the protocol depends on the diagnosis.
Revisado por Dr. Claudia Labastida · 2026-05-27
The indications we most frequently evaluate are knee and joint osteoarthritis, lumbar and cervical spine pain, autoimmune conditions (lupus, Hashimoto's, multiple sclerosis), fibromyalgia and chronic fatigue, androgenetic alopecia, sexual wellness conditions, long COVID, sports injuries, type 2 diabetes as a metabolic adjunct, and anti-aging programs. Every case is individually evaluated — stem cell therapy is investigational for many indications, and we will tell you honestly when it is not the right tool.
Revisado por Dr. Claudia Labastida · 2026-05-27
Yes, when sourced and processed under regulated conditions. Wharton's-jelly MSCs come from screened, ethically donated post-birth umbilical cord tissue — collection does not affect the parents or newborn. Donors undergo comprehensive medical and infectious-disease screening that meets ISBT and ISCT consensus guidance. MSCs are also immunoprivileged, meaning they can be administered without HLA matching in carefully screened protocols. Our cellular product chain is COFEPRIS-certified with full traceability for every batch.
Revisado por Dr. Claudia Labastida · 2026-05-27
Most U.S. and international private insurers currently do not reimburse regenerative cellular therapy because it remains investigational for many indications. Some patients use HSA/FSA accounts, medical-credit lines, or self-funding. We provide itemized clinical and financial documentation that some patients have successfully used for HSA reimbursement or for tax purposes. We recommend confirming with your insurer in writing before booking. See our dedicated guide for international patients on insurance and financing.
Revisado por Dr. Claudia Labastida · 2026-05-27
Regenerative medicine sits in an active research space — neither hype nor magic. We follow the published literature on MSC efficacy and safety, set realistic patient expectations, and refuse to oversell. Our research page collects the peer-reviewed sources we rely on, organized by indication.
ISCT MSC consensus
ISBT donor screening
COFEPRIS regulated
Peer-reviewed literature
Knee osteoarthritis (gonarthrosis, ICD-10 M17) is the progressive wear of the cartilage that covers the femur, tibia and patella. At Regeneris Therapy we combine current clinical evidence and regenerative medicine to reduce pain, improve mobility and, in selected cases, postpone or avoid total knee replacement.
Learn about this conditionFibromyalgia is real, medical and deserves an honest approach. At Regeneris Therapy we combine regenerative medicine, IV therapy and an integrative protocol to help you recover energy, sleep and quality of life — always alongside your rheumatologist.
Learn about this conditionLupus is a serious, lifelong autoimmune disease. The cornerstone of care is a rheumatologist and disease-modifying medication — regenerative protocols are only an investigational adjunct that we coordinate around your treating physician, never a replacement.
Learn about this conditionThe most common cause of hypothyroidism. At Regeneris we combine conventional endocrinology with functional medicine, nutrition, and IV therapy to help you feel like yourself again.
Learn about this conditionAndrogenetic alopecia is the most common cause of progressive hair loss in men and women. Below we explain how it develops, what regenerative therapies can realistically offer, and how our physicians at Regeneris build a plan around your specific pattern of thinning.
Learn about this conditionA clear, medically grounded introduction to mesenchymal stem cells, where they come from, and why laboratory standards matter.
Your no-hype, science-backed starting point for regenerative treatment in Mexico.
A clear guide to the difference between autologous and allogeneic stem cells: pros, cons, clinical contexts, and how to choose based on your condition.
The honest first question is whether you're a candidate. A 15-minute consultation with a licensed Regeneris physician will tell you, with no obligation to proceed. We treat the consultation as a clinical conversation, not a sales call.
Stem cell therapy is investigational for many indications. Results vary by patient. Individualized medical evaluation is required before any protocol is recommended.
